Company: Dana-Farber Cancer Institute
Job title: Assistant Professor
John Koreth, MBBS DPhil, is a Hematology-Oncology Attending Physician in Blood and Marrow Transplantation (BMT) at Dana-Farber Cancer Institute, Associate Member of Brigham & Women’s Hospital, and Associate Professor of Medicine at Harvard Medical School.
Dr. Koreth is a graduate of the University of Delhi, India and Oxford University, UK. He trained in internal medicine at Brigham & Women’s Hospital and hematology-oncology at Dana-Farber/Partners Cancer Care. He completed post-doctoral research training with Drs. Stuart Orkin (Dana-Farber) and Sander van den Heuvel (Massachusetts General Hospital).
Dr. Koreth’s clinical and translational research seeks to optimize BMT utilization in various hematologic malignancies including multiple myeloma, acute myeloid leukemia and myelodysplastic syndroms, and to improve outcomes in advanced/aggressive hematologic malignancies – with a special focus on immune modulation strategies for control of graft-versus-host disease (GvHD), a major transplantation toxicity. His work on augmenting anti-inflammatory regulatory T cells also has implications beyond GvHD. Dr. Koreth’s honors include a Rhodes scholarship, Claudia Adams Barr Award, Dunkin Donuts Rising Star Award, American Society of Transplantation and Cellular Therapy (ASTCT) New Investigator Award, Leukemia and Lymphoma Society Scholar in Clinical Research Award. He is a member of the American Society of Hematology and ASTCT.
Panel Discussion: Exploring the Various Treg Directed Approaches 4:30 pm
Highlighting the impoartance of furthering the understanding of Treg cell biology including exploring the relevant mechanisms of action Addressing how to improve and expand Treg cell manufacturing and engineering How can clincal outcomes regulatory T cell therapies be improved?Read more
day: Day One